Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

× No keyword cloud information.

7 in total

1. Further studies on the chemotactic factor of complement and its formation in vivo.

Authors: P A Ward; C G Cochrane; H J Muller-Eberhard
Journal: Immunology Date: 1966-08 Impact factor: 7.397

2. Macrophage and neutrophil specific chemotactic factors in serum.

Authors: P C Wilkinson; J F Borel; V J Stecher-Levin; E Sorkin
Journal: Nature Date: 1969-04-19 Impact factor: 49.962

3. Studies on chemotaxis. XII. Generation of chemotactic activity for polymorphonuclear leucocytes in sera with complement dificiencies.

Authors: V J Stecher; E Sorkin
Journal: Immunology Date: 1969-02 Impact factor: 7.397

4. A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin.

Authors: R Snyderman; H S Shin; J K Phillips; H Gewurz; S E Mergenhagen
Journal: J Immunol Date: 1969-09 Impact factor: 5.422

5. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.

Authors: A B Kay
Journal: Clin Exp Immunol Date: 1970-11 Impact factor: 4.330

6. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors: S BOYDEN
Journal: J Exp Med Date: 1962-03-01 Impact factor: 14.307

7. The eighth component of human complement (C8): isolation, characterization, and hemolytic efficiency.

Authors: J A Manni; H J Müller-Eberhard
Journal: J Exp Med Date: 1969-11-01 Impact factor: 14.307

7 in total

22 in total

1. Primary restrictive cardiomyopathy. Non-tropical endomyocardial fibrosis and hypereosinophilic heart disease.

Authors: C Y Chew; G M Ziady; M J Raphael; M Nellen; C M Oakley
Journal: Br Heart J Date: 1977-04

2. The recruitment of inflammatory cells using the skin-window technique.

Authors: T C Dikeacou; T van Joost; R H Cormane
Journal: Arch Dermatol Res Date: 1979-05-29 Impact factor: 3.017

3. Modulation of the random migration of human platelets.

Authors: F H Valone; K F Austen; E J Goetzl
Journal: J Clin Invest Date: 1974-11 Impact factor: 14.808

4. Hereditary deficiency of the seventh component of complement.

Authors: J T Boyer; E P Gall; M E Norman; U R Nilsson; T S Zimmerman
Journal: J Clin Invest Date: 1975-10 Impact factor: 14.808

Review 5. Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors: J S Sundsmo; D S Fair
Journal: Springer Semin Immunopathol Date: 1983

6. Influence of serum-derived chemotactic factors and bacterial products on human neutrophil chemotaxis.

Authors: A C Issekutz; W D Biggar
Journal: Infect Immun Date: 1977-01 Impact factor: 3.441

7. Constituents of human neutrophils that mediate enhanced adherence to surfaces: purification and identification as acidic proteins of the specific granules.

Authors: L K Bockenstedt; E J Goetzl
Journal: J Clin Invest Date: 1980-06 Impact factor: 14.808

Review 8. Mast cell-dependent effector pathways and cutaneous bullous disorders.

Authors: B U Wintroub; M C Mihm
Journal: Springer Semin Immunopathol Date: 1981-06

9. Platelet factor 4 is chemotactic for neutrophils and monocytes.

Authors: T F Deuel; R M Senior; D Chang; G L Griffin; R L Heinrikson; E T Kaiser
Journal: Proc Natl Acad Sci U S A Date: 1981-07 Impact factor: 11.205

10. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator.

Authors: A P Kaplan; E J Goetzl; K F Austen
Journal: J Clin Invest Date: 1973-10 Impact factor: 14.808